Apellis Pharmaceuticals
APLS
APLS
168 hedge funds and large institutions have $3.65B invested in Apellis Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 51 increasing their positions, 60 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 145 → 168 (+23)
2.16% more ownership
Funds ownership: 82.2% → 84.36% (+2.2%)
15% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 60
Holders
168
Holding in Top 10
6
Calls
$16.3M
Puts
$6.96M
Top Buyers
| 1 | +$70M | |
| 2 | +$49.9M | |
| 3 | +$18.6M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$17.2M |
| 5 |
Renaissance Technologies
New York
|
+$12.4M |
Top Sellers
| 1 | -$43.8M | |
| 2 | -$38.6M | |
| 3 | -$33.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$24.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.2M |